Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children

Journal of Lower Genital Tract Disease

Volumn 14, Issue 3, 2010, Pages 179-184

  Ferris, Daron G ^a   Cromwell, Lee ^a   Waller, Jennifer L ^a   Horn, Leslie ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b Department of Family Medicine and Obstetrics and Gynecology Medical College of Georgia ^*

Author keywords

human papillomavirus; questionnaire; sexual intercourse; vaccine

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CHILD; COMPARATIVE STUDY; DEMOGRAPHY; FEMALE; HEALTH INSURANCE; HUMAN; MALE; PARENTAL ATTITUDE; RELIGION; RISK REDUCTION; SEXUAL BEHAVIOR; STRUCTURED QUESTIONNAIRE; UTERINE CERVIX CANCER; WART VIRUS; ADOLESCENT; ATTITUDE TO HEALTH; GEORGIA; IMMUNOLOGY; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PARENT; PATIENT ATTITUDE; PSYCHOLOGY; QUESTIONNAIRE; UNITED STATES;

ADOLESCENT; ADULT; CHILD; FEMALE; GEORGIA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; SEXUAL BEHAVIOR; SOUTH CAROLINA;

EID: 77954940487     PISSN: 10892591     EISSN: None     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3181d41806     Document Type: Article

References (23)

1. Villa LL, Costa RLR, Petta CA, Andrade RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a randomized double-blind placebocontrolled multicentre phase II efficacy trial. Lancet Oncol 2005;6:271-8.
2. The FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27.
3. The FUTURE II Study Group. Effect of prophylactic human papillomavirus L1 virus-like-particle vaccine on risk of cervical intraepithelial neoplasia grade 2, grade 3 and adenocarcinoma in situ. A combined analysis of four randomized clinical trials. Lancet 2007;369:1861-8
4. Garland SM, Hernandez-Avila M, Wheeler CM, Perez G, Harper DM, Leodolter S, et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med 2007;356:1928-43.
5. Munoz N, Manalastas R Jr, Pitisuttithum P, Tresukosol D, Monsonego J, Ault K, et al. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11,16, 18) recombinant vaccine in women aged 25-45 years:a randomized, double-blind trial. Lancet 2009;373:1949-57.
6. Wheeler CM, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Perez G, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16 and 18) L1 viruslikeparticle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years. J InfectDis 2009;199:936-44.
7. Brown DR, Kjaer SK, Sigurdsson K, Iversen OE, Hernandez-Avila M, Wheeler CM, et al. The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16 and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naBve women aged 16-26 years. J Infect Dis 2009;199:926-35.
8. Joura EA, Kjaer SK, Wheeler CM, Sigurdsson K,Iversen OE, Hernandez-Avila M, et al. HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine. Vaccine 2008;26:6844-51.
9. Slade BA, Leidel L, Vellozzi C, Woo EJ, Huu W, Sutherland A, et al. Post licensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA2009;302:750-7.
10. Pollitt K. Virginity or death! The Nation. May 30, 2005. Available at: http://www.thenation.com/doc/20050530/pollitt/print.
11. Gibbs N. Defusing the war over the Bpromiscuity[ vaccine. Time. June 21, 2006. Available at: http://www.time.com/ time/printout/0,8816,1206813,00.html.
12. ORourke M. Cancer sluts. Does the HPV vaccine Bpromote[ promiscuity? Slate. September 27, 2007.Available at: http://www.slate.com/toolbar.aspx? action=print+id=2174850.
13. Revoir P. Watchdog bans Christian advert that claims cervical cancer vaccine causes infertility. Mail online. January 28, 2009. Available at: http://www.dailymail.co.uk/news/article-1130007.
14. Graham KC. Cancer vaccine causes premarital sex? Religion Dispatches. September 25, 2008. Available at: http:// religiondispatches.org/dialogs/print/? id=530.
15. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomavirus vaccine acceptability among parents of 10- to 15-year-old adolescents. J Lower Gen Tract Dis 2004;8: 188-94.
16. Ferris DG, Waller JC, Owen A, Smith J. Mid-adultwomens attitudes about receiving the prophylactic human papillomavirus vaccine. J Lower Gen Tract Dis 2007;11: 166-72.
17. Ferris DG, Waller JL, Miller J, Patel P, Jackson L, Price GA, et al. Mens attitudes toward receiving the human papillomavirus vaccine. J Lower Gen Tract Dis 2008;12: 276-81.
18. Marlow LAV, Forster AS, Wardle J, Waller J. Mothers and adolescents beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009;44:446-51.
19. Marlow LAV, Waller J, Wardle J. Parental attitudes to pre-pubertal HPV vaccination. Vaccine 2007;25:1945-52.
20. Marshall H, Ryan P, Robertson D, Baghurst P. A crosssectional survey to assess community attitudes to introduction of human papillomavirus vaccine. Aust N Z J Public Health 2007;31:235-42.
21. Monk BJ, Wiley DJ. Will widespread human papillomavirus prophylactic vaccination change sexual practicesof adolescent and young adult women in America? Obstet Gynecol 2006;108:420-4.
22. Haber G, Malow RM, Zimet GD. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol 2007;20: 325-31.
23. Zimet GD, Liddon N, Rosenthal SL, Lazcano-Ponce E, Allen B. Chapter 24: psychosocial aspects of vaccine acceptability. Vaccine 2006;S3:201Y9.